Study guide
3.9 SRS, SBRT & Stereotactic Radiosurgery Techniques
ARRT Radiation Therapy Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Patient Care & Education
1.1 Patient Assessment, History, and Vital Signs 1.2 Psychosocial Support & Coping Mechanisms 1.3 Patient & Family Education on Radiation Therapy 1.4 Radiation Side Effect Management: Skin & Mucosal Reactions 1.5 Radiation Side Effect Management: Systemic & Organ-Specific Side Effects 1.6 Nutritional Support & Management of Dysphagia/Odynophagia 1.7 Medical Emergencies in Radiation Oncology 1.8 Patient Rights, Informed Consent, and Advanced Directives 1.9 Ethical, Legal, and HIPAA Considerations for Radiation Therapists 1.10 Infection Control & Sterile Technique in Radiation Therapy 1.11 Transfer & Positioning Safety for Oncology Patients 1.12 Pharmacology & Contrast Media in Radiation Therapy 1.13 Cancer Epidemiology, Screening & Diagnostic Evaluation
2 Chapter 2: Radiation Physics, Radiobiology & Protection
2.1 Structure of Matter, Electromagnetic & Particulate Radiation 2.2 Radiation Production in Linear Accelerators & X-Ray Tubes 2.3 Photon & Electron Beam Interactions with Matter 2.4 Radiation Measurement Quantities, Units & Dosimeters 2.5 Radiation Protection Principles: ALARA, Time, Distance & Shielding 2.6 NCRP Dose Limits for Occupational & Public Exposure 2.7 Vault Design, Primary & Secondary Protective Barriers 2.8 Radiobiology Principles: Cell Survival Curves & Radiosensitivity (4 R's) 2.9 Linear Energy Transfer (LET) & Relative Biological Effectiveness (RBE) 2.10 Acute & Late Radiation Effects on Normal Tissues 2.11 Radiation Safety Rules, Emergency Procedures & Sealed Source Safety 2.12 MRI Magnetic Field Screening for Radiation Therapy Patients
3 Chapter 5: Treatment Sites, Tumors & Classification
5.1 Brain, Spinal Cord Tumors & Metastatic Patterns 5.2 Head & Neck Sites: Anatomy, Lymphatics & Patterns of Spread 5.3 Breast Cancer: Anatomy, Lymphatic Drainage & Radiation Considerations 5.4 Lung & Thoracic Tumors: Anatomy, Spread & Critical Structures 5.5 Abdomen, Pelvis, GI & GU Sites: Anatomy & Metastatic Patterns 5.6 Reproductive System Tumors: Prostate, Cervix & Related Sites 5.7 Lymphoma, Sarcoma, Skin, Leukemia & Oncologic Emergencies 5.8 Tumor Classification: Histopathology, Grade & Staging Systems
4 Chapter 3: Treatment Planning & Dosimetry
3.1 CT Simulation, Patient Positioning & Target Localization 3.2 Immobilization Devices & Radiopaque Marking Protocols 3.3 ICRU Target Volume Definitions (GTV, CTV, PTV, PRV, OAR) 3.4 Beam Modifiers: Wedges, Compensators, Bolus & MLC Systems 3.5 Depth Dose Characteristics: PDD, TMR, TPR & TAR Relationships 3.6 Monitor Unit (MU) Calculations & Clinical Dosimetry Formulas 3.7 3D Conformal Radiation Therapy (3D-CRT) Beam Arrangements 3.8 IMRT, VMAT & Inverse Planning Optimization Concepts 3.9 SRS, SBRT & Stereotactic Radiosurgery Techniques 3.10 Brachytherapy Principles, HDR, LDR & Isotopes 3.11 Dose Volume Histograms (DVH) & QUANTEC Tissue Tolerances
5 Chapter 4: Treatment Delivery, Image Guidance & QA
4.1 Pre-Treatment Chart Check & Plan Verification Protocols 4.2 Daily Patient Positioning, Setup Tolerances & Alignment Verification 4.3 Image-Guided Radiation Therapy (IGRT): Portal Imaging & CBCT Verification 4.4 Linear Accelerator Safety Systems, Interlocks & Gantry Controls 4.5 Special Techniques: TBI, TSI, SGRT & Gated Radiotherapy 4.6 Daily Linac Quality Assurance per AAPM TG-142 Specifications 4.7 Monthly & Annual Linac QA Requirements & Dosimetric Calibration 4.8 Patient-Specific IMRT QA & In-Vivo Dosimetry Verification 4.9 Machine Malfunctions, Override Protocols & Emergency Off Procedures 4.10 Record and Verify (R&V) Systems, EHR Integration & Treatment Documentation
3.9 SRS, SBRT & Stereotactic Radiosurgery Techniques
Key Takeaways Explain This Topic AI
Stereotactic Radiosurgery (SRS) delivers single-fraction high-dose radiation (15-24 Gy) to cranial targets with spatial accuracy within 1.0 mm.
Stereotactic Body Radiation Therapy (SBRT/SABR) delivers 3 to 5 hypofractionated doses (e.g., 48-60 Gy total) to extracranial targets.
Small-field dosimetry in SRS/SBRT requires micro-chambers or diodes to overcome detector volume averaging and loss of lateral equilibrium.
Conformity Index (CI = V_RI / TV) and Gradient Index (GI = V_50% / V_100%) quantify dose steepness and falloff in stereotactic planning.
Gamma Knife utilizes 192 Cobalt-60 sources focused through helmet collimators to treat intracranial targets with sub-millimeter precision.
Last updated: July 2026
Definitions: SRS, SRT, and SBRT (SABR)
Stereotactic radiation therapy delivers ablative biological radiation doses using narrow, highly conformal radiation beams coupled with rigid stereotactic target localization and sub-millimeter positioning accuracy. +-----------------------------------+ +-----------------------------------+
- | Stereotactic Radiosurgery (SRS) | | Stereotactic Body RT (SBRT/SABR) |
- | Intracranial Targets (Brain/Spine)| | Extracranial Targets (Lung/Liver) |
- | 1 Single Fraction (15 – 24 Gy) | | 1 – 5 Fractions (48 – 60 Gy Total)|
- +-----------------------------------+ +-----------------------------------+
- 1. Stereotactic Radiosurgery (SRS)
Single-fraction high-dose ablative radiation delivered to intracranial targets (e.g., brain metastases, acoustic neuromas, arteriovenous malformations [AVM], trigeminal neuralgia). Prescribed dose ranges from 15 Gy to 24 Gy in 1 single fraction .
2. Fractionated Stereotactic Radiotherapy (SRT)
Intracranial stereotactic treatment delivered in 2 to 5 hypofractionated doses (e.g., 24–30 Gy in 3 fractions) for lesions located immediately adjacent to sensitive structures like the optic chiasm or brainstem to minimize normal tissue toxicity.
3. Stereotactic Body Radiation Therapy (SBRT / SABR)
Extracranial stereotactic treatment delivered in 1 to 5 hypofractionated fractions to thoracic, abdominal, pelvic, or spinal targets (e.g., stage I non-small cell lung cancer, liver oligometastases, localized prostate cancer, spine lesions). Typical dose fractionation schemes include:
50 Gy in 4 or 5 fractions (10–12.5 Gy per fraction).
48 Gy in 4 fractions or 60 Gy in 3 fractions (lung SBRT).
16–24 Gy in 1 single fraction (spine stereotactic radiosurgery).
- Dedicated Stereotactic Treatment Platforms [ Leksell Gamma Knife ] [ CyberKnife Robotic System ]
- 192 Cobalt-60 Fixed Sources 6 MV Compact Linac on KUKA Robot Arm
- Tungsten Collimator Helmets Real-Time X-Ray Target Tracking
- Intracranial Single-Fx Only Full Body (Intracranial & Extracranial)
- 1. Leksell Gamma Knife (Elekta)
Utilizes 192 Cobalt-60 ( 60 Co ^{60}\text{Co} 60 Co ) radioactive sources arranged in a hemispherical vault. Beams converge through primary tungsten collimators and secondary helmets (4 mm, 8 mm, 16 mm apertures) onto a single focal isocenter. Rigid invasively pinned stereotactic skull frames achieve sub-millimeter mechanical spatial accuracy ( < 0.5 mm ). Exclusively used for single-fraction intracranial radiosurgery.
2. CyberKnife (Accuray)
Mounts a compact 6 MV X-band linear accelerator onto a KUKA robotic arm with 6 degrees of freedom. Tracks target movement in real time during treatment using twin ceiling-mounted X-ray imaging cameras that detect internal fiducial markers or skeletal landmarks (SynchroNY tracking system). Requires no rigid invasive head frame, allowing frameless full-body intracranial and extracranial treatments.
3. Dedicated C-Arm Linear Accelerators
Standard C-arm linear accelerators upgraded for stereotactic delivery, equipped with High-Definition Multi-Leaf Collimators (HD-MLCs, 2.5 mm leaf width) , high dose-rate Flattening Filter Free (FFF) beam modes (up to 1400–2400 MU/min), Surface Guided Radiation Therapy (SGRT), and cone-beam CT (CBCT) capable of 6D robotic couch corrections (pitch, roll, yaw).
- Parameter Conventional RT Stereotactic Radiosurgery (SRS) Stereotactic Body RT (SBRT)
- Anatomical Site Full Body Intracranial Brain / Spine Extracranial (Lung, Liver, Spine)
Fractionation 25 – 44 fractions (1.8 – 2.0 Gy/fx) 1 single fraction (15 – 24 Gy/fx) 1 – 5 fractions (8 – 18 Gy/fx)
- Total Dose 45 Gy – 78 Gy 15 Gy – 24 Gy 48 Gy – 60 Gy (e.g. 50 Gy in 4–5 fx)
- Spatial Accuracy 3.0 mm – 5.0 mm < 1.0 mm (Sub-millimeter) < 1.5 mm – 2.0 mm
- Target Margin (PTV) 5 mm – 15 mm 0 mm – 2 mm 2 mm – 5 mm
- Dose Falloff Moderate Extreme (Steep Gradient) Extreme (Steep Gradient)
- Physics of Steep Dose Falloff and Small-Field Dosimetry
- Steep Isodose Falloff Metrics
Stereotactic plans require an extremely steep dose gradient outside the target volume to protect adjacent normal tissues.
RTOG Conformity Index (CI): CI RTOG = V RI TV \text{CI}_{\text{RTOG}} = \frac{V_{\text{RI}}}{\text{TV}} CI RTOG = TV V RI
Where V RI V_{\text{RI}} V RI is the volume enclosed by the prescription isodose line, and TV \text{TV} TV is the target volume (PTV). Ideal value is 1.0 to 1.2 .
Gradient Index (GI): GI = V 50 % V 100 % \text{GI} = \frac{V_{50\%}}{V_{100\%}} GI = V 100% V 50%
Where V 50 % V_{50\%} V 50% is the volume receiving 50% of the prescription dose, and V 100 % V_{100\%} V 100% is the prescription volume. A low Gradient Index ( GI < 3.0 \text{GI} < 3.0 GI < 3.0 ) confirms rapid dose falloff into surrounding normal brain or tissue.
Small-Field Dosimetry Challenges
Fields smaller than 3 × 3 cm 2 3 \times 3\text{ cm}^2 3 × 3 cm 2 introduce severe physical measurement challenges:
Loss of Lateral Charged Particle Equilibrium (CPE): Secondary electron range exceeds beamlet width, causing central axis dose collapse.
Source Occlusion: Collimator jaws partially block the primary focal spot (1–2 mm), underestimating dose.
Detector Volume Averaging: Standard 0.6 cc Farmer ionization chambers are larger than the small radiation field, causing severe underestimation of peak central dose. Micro-chambers (0.01 cc), synthetic diamond detectors, or unshielded diodes are mandatory.
Target Volumes & Motion Management: ITV Concepts
Extracranial targets in the chest and abdomen move dynamically during patient respiration, requiring specialized volume expansion and motion management. [ Gross Tumor Volume (GTV) ]
- |
- v
- [ Clinical Target Volume (CTV) ] ---> + 4D-CT Respiratory Motion Envelope
- | |
- v v
- [ Internal Target Volume (ITV) ] <-----------------+
- |
- v + Setup Uncertainty Margin (2 – 5 mm)
- [ Planning Target Volume (PTV) ]
- 1. 4D-CT Simulation
Acquires CT images correlated with a respiratory belt or surface tracking signal. Images are sorted into 10 respiratory phase bins (0% peak inhalation to 50% peak exhalation).
2. Internal Target Volume (ITV)
Defined by enveloping the Clinical Target Volume (CTV) across all breathing phases of the 4D-CT scan: ITV = CTV + Internal Margin (Respiration Motion) \text{ITV} = \text{CTV} + \text{Internal Margin (Respiration Motion)} ITV = CTV + Internal Margin (Respiration Motion)
3. Planning Target Volume (PTV)
Expands upon the ITV to account for mechanical daily positioning and alignment uncertainties: PTV = ITV + Setup Margin (2 – 5 mm) \text{PTV} = \text{ITV} + \text{Setup Margin (2 – 5 mm)} PTV = ITV + Setup Margin (2 – 5 mm)
4. Respiratory Motion Management Strategies
Active Breathing Control (ABC) / Deep Inspiration Breath-Hold (DIBH): Temporarily holds patient breathing at a reproducible lung volume to freeze target motion during beam delivery.
Respiratory Gating: Delivers radiation only when the tumor moves within a pre-defined window of the breathing cycle (e.g., 40% to 60% end-exhalation phase).
Real-Time Target Tracking: Continuously repositions the radiation beam (or robotic arm) in sync with moving internal markers (e.g., CyberKnife SynchroNY).